WEST PHARMACEUTICAL SERVICES, INC. Unrealized Gain (Loss) on Investments
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Unrealized Gain (Loss) on Investments of -$1.80 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-10-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2021-10-28
- 2021-09-30: Unrealized Gain (Loss) on Investments 9 month -$1.80M.
| Period end | Unrealized Gain (Loss) on Investments 9 month |
|---|---|
| 2021-09-30 | -$1.80M 10-Q · filed 2021-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |